CPDA-1
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- CPDA-1
- Generic name
- ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE
- Manufacturer
- Fenwal, Inc.
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 794f724c-87f0-49c1-9b26-c9e491978313
- SPL ID
- 24a1bb0c-2b88-4dd5-a20a-b803388e9954
- Version
- 10
- Effective date
- 2019-11-18
- Source export date
- 2026-11-06
- Source partition
- 14
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0014-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-11-06/2cac198adf50bf0f7077ca012f418bbee1fb171f907f83d6a83048d9770d345b/drug-label-0014-of-0014.json.zip
- Source manifest SHA-256
- 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
- Import run
- 20261108T063105Z
- Imported at
- 2026-11-08 08:11:42
| Harmonized routes |
|---|
| INTRAVENOUS |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application number | BN770420 | openfda.application_number | |
| brand name | CPDA-1 | openfda.brand_name | |
| generic name | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | openfda.generic_name | |
| manufacturer name | Fenwal, Inc. | openfda.manufacturer_name | |
| ndc | package | 0942-6308-02 | openfda.package_ndc |
| ndc | product | 0942-6308 | openfda.product_ndc |
| ndc11 | package | 00942630802 | derived:openfda.package_ndc |
| spl id | 24a1bb0c-2b88-4dd5-a20a-b803388e9954 | id | |
| spl set id | 794f724c-87f0-49c1-9b26-c9e491978313 | set_id | |
| unii | JAC85A2161 | openfda.unii | |
| unii | XF417D3PSL | openfda.unii | |
| unii | B22547B95K | openfda.unii | |
| unii | LX22YL083G | openfda.unii | |
| unii | 593YOG76RN | openfda.unii |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.